1. Biology of Blood and Marrow Transplantation
Reach-2 Trial Design: A Phase 3, Randomized, Open-Label, Multicenter Study to Evaluate Ruxolitinib Compared to Best Available Therapy in Patients with Corticosteroid-Refractory Acute Graft vs Host Disease after Allogeneic Stem Cell Transplantation 
Gérard Socié, Dietger Niederwieser, Nikolas von Bubnoff, Jeff Szer, Mohamad Mohty, Mary Laughlin, Betty Molloy, Leslie O'Sullivan- Djentuh, Robert Zeiser 
Biology of Blood and Marrow Transplantation 
Volume 24, Issue 3, (March 2018)
DOI: /j.bbmt
Copyright © Terms and Conditions

2. Figure 1
Study design.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © Terms and Conditions